Hostname: page-component-848d4c4894-x24gv Total loading time: 0 Render date: 2024-05-21T17:43:07.206Z Has data issue: false hasContentIssue false
  • English
  • Français

NMS and genetic drug oxidation

Published online by Cambridge University Press:  02 January 2018

Koichi Otani ,
Sunao Kaneko ,
Yutaka Fukushima ,
Kan Chiba  and
Takashi Ishizaki
Koichi Otani
Affiliation:
Department of Neuropsychiatry Hirosaki University Hospital Hirosaki, Japan
Sunao Kaneko
Affiliation:
Department of Neuropsychiatry Hirosaki University Hospital Hirosaki, Japan
Yutaka Fukushima
Affiliation:
Department of Neuropsychiatry Hirosaki University Hospital Hirosaki, Japan
Kan Chiba
Affiliation:
Department of Neuropsychiatry Hirosaki University Hospital Hirosaki, Japan
Takashi Ishizaki
Affiliation:
Clinical Research Institute National Medical Center Tokyo, Japan
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Columns
Information
The British Journal of Psychiatry , Volume 159 , Issue 4 , October 1991 , pp. 595 - 596
Copyright
Copyright © 1991 The Royal College of Psychiatrists 

References

Bertilsson, L., Henthorn, T. K., Sanz, E., et al (1989) Importance of genetic factors in the regulation of diazepam metabolism: relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotype. Clinical Pharmacology & Therapeutics, 45, 348–355.Google Scholar
Dahl-Puustinen, M-L., Lidén, A., Alm, C., et al (1989) Disposition of perphenazine is related to polymorphic debrisoquin hydroxylation in human being. Clinical Pharmacology & Therapeutics, 46, 78–81.Google Scholar
Gram, L. F., Debruyne, D., Caillard, V., et al (1989) Substantial rise in sparteine metabolic ratio during haloperidol treatment. British Journal of Clinical Pharmacology, 27, 272–275.Google Scholar
Horai, Y., Nakano, M., Ishizaki, T., et al (1989) Metoprolol and mephenytoin oxidation polymorphisms in far eastern oriental subjects: Japanese versus mainland Chinese. Clinical Pharmacology & Therapeutics, 46, 198–207.Google Scholar
Santos, J. L., Cabranes, J. A., Almoguera, J., et al (1989) Clinical implications of determination of plasma haloperidol levels. Acta Psychiatrica Scandinavica, 79, 348–354.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.